Rakuten Medical, Inc.
Wednesday, June 05, 2024
Company Presentation
![Oncology](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/BIO-track-icon_Oncology_MTC.png)
Company Presentation Theater 1
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies based on its Alluminox™ technology platform, which has been shown to induce rapid and selective cell killing and tumor necrosis. Our lead product ASP-1929 is conditionally approved and commercially available in Japan and is currently being evaluated in a global phase 3 clinical study. Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives.
![Rakuten Medical, Inc.](https://www.abstractscorecard.com/uploads/Tasks/upload/21754/XDQDGWMO-1810445-1-JPG.jpg)
Company Website:
https://rakuten-med.com/us/
Lead Product in Development:
ASP-1929
Company HQ City
San Diego
Company HQ State
California
Company HQ Country
United States
CEO/Top Company Official
Hiroshi "Mickey"Mikitani
Development Phase of Primary Product
Phase III
Primary Speaker